Skye Bioscience, Inc.SKYENASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank85
3Y CAGR+67.8%
5Y CAGR+19.0%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+67.8%/yr
vs -9.5%/yr prior
5Y CAGR
+19.0%/yr
Recent acceleration
Acceleration
+77.3pp
Accelerating
Percentile
P85
Within normal range
vs 5Y Ago
2.4x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.88M | -91.4% |
| 2024 | $68.42M | +5345.1% |
| 2023 | $1.26M | +1.0% |
| 2022 | $1.24M | -86.1% |
| 2021 | $8.98M | +263.8% |
| 2020 | $2.47M | +34.9% |
| 2019 | $1.83M | -1.3% |
| 2018 | $1.85M | +613.0% |
| 2017 | $259955.00 | +301.0% |
| 2016 | $64820.00 | - |